Abstract
The bone mass was measured by dual energy X-ray absorptiometry in 25 survivors of childhood leukaemia or lymphoma (21 with ALL) who had received TBI and allogeneic BMT a median of 8 years ago (range 4–13). Results were compared with local data on 463 healthy controls and 95 survivors of childhood ALL treated without BMT. Adjusted for sex and age, the mean whole-body bone mineral content (BMC) and bone mineral areal density were significantly less than in healthy controls (0.8 and 0.5 s.d. less than predicted). The reduced BMC was caused by a significantly reduced height for age, whereas bone area for height and BMC for bone area were similar to controls. Less bone mass tended to be related to additional cranial irradiation and age above 20 years at follow-up. Controlled for this, the whole-body bone mass seemed to be unrelated to previous chemotherapy and endocrine status at follow-up and tended to be only marginally less in BMT patients than in ALL survivors treated without BMT. In conclusion, 8 years after allogeneic BMT for childhood leukaemia or lymphoma, the whole-body bone mass was only slightly reduced and the size-adjusted bone mass (BMC for bone area) was normal. Bone Marrow Transplantation (2000) 25, 191–196.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
de Nully Brown P, Olsen JH, Hertz H et al. Trends in survival after childhood cancer in Denmark, 1943–87: a population-based study Acta Paediatr 1995 84: 316–324
Saarinen UM, Mellander L, Nysom K et al. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case–control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO) Bone Marrow Transplant 1996 17: 357–363
Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission (see comments) New Engl J Med 1994 331: 1253–1258
Dopfer R, Henze G, Bender-Götze C et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study Blood 1991 78: 2780–2784
Schroeder H, Gustafsson G, Saarinen-Pihkala UM et al. Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukaemia: a population-based case control study from the Nordic countries Bone Marrow Transplant 1999 23: 555–560
Shalet SM, Didi M, Ogilvy-Stuart AL et al. Growth and endocrine function after bone marrow transplantation Clin Endocrinol 1995 42: 333–339
Holm K, Nysom K, Rasmussen MH et al. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency BoneMarrow Transplant 1996 18: 163–170
Cohen A, Rovelli A, Bakker B et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT Blood 1999 93: 4109–4115
Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation Blood 1996 87: 3045–3052
Pihkala J, Saarinen UM, Lundstrom U et al. Effects of bone marrow transplantation on myocardial function in children Bone Marrow Transplant 1994 13: 149–155
Nysom K, Holm K, Hesse B et al. Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma Arch Dis Child 1996 74: 432–436
Shalet SM . Radiation and pituitary dysfunction (editorial; comment) New Engl J Med 1993 328: 131–133
Holmes SJ, Shalet SM . Role of growth hormone and sex steroids in achieving and maintaining normal bone mass Horm Res 1996 45: 86–93
Rosén T, Wilhelmsen L, Landin-Wilhelmsen K et al. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency Eur J Endocrinol 1997 137: 240–245
Canalis E . Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis J Clin Endocrinol Metab 1996 81: 3441–3447
Ragab AH, Frech RS, Vietti TJ . Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission Cancer 1970 25: 580–585
Nesbit M, Krivit W, Heyn R, Sharp H . Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems Cancer 1976 37: 1048–1057
O'Regan S, Melhorn DK, Newman AJ . Methotrexate-induced bone pain in childhood leukemia Am J Dis Child 1973 126: 489–490
Koller A, Fill H, Kurz R et al. Osteopathy due to methotrexate Osterr Kneipp Mag 1976 3: 63–69
Kelly PJ, Atkinson K, Ward RL et al. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation Transplantation 1990 50: 881–883
Castelo Branco C, Rovira M, Pons F et al. The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation Maturitas 1996 23: 307–312
Castañeda S, Carmona L, Carvajal I et al. Reduction of bone mass in women after bone marrow transplantation Calcif Tissue Int 1997 60: 343–347
Bhatia S, Ramsay NK, Weisdorf D et al. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies Bone Marrow Transplant 1998 22: 87–90
Valimaki MJ, Kinnunen K, Volin L et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin Bone Marrow Transplant 1999 23: 355–361
Ebeling PR, Thomas DM, Erbas B et al. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation J Bone Miner Res 1999 14: 342–350
Nysom K, Holm K, Michaelsen KF et al. Bone mass after treatment for acute lymphoblastic leukemia in childhood J Clin Oncol 1998 16: 3752–3760
Thomas ED, Storb R, Clift A et al. Bone marrow transplantation New Engl J Med 1975 292: 895–902
Mølgaard C, Thomsen BL, Prentice A et al. Whole body bone mineral content in healthy children and adolescents (see comments) Arch Dis Child 1997 76: 9–15
Nysom K, Mølgaard C, Michaelsen KF . Bone mineral density in the lumbar spine as determined by dual-energy X-ray absorptiometry. Comparison of whole-body scans and dedicated regional scans Acta Radiol 1998 39: 632–637
Andersson AM, Juul A, Petersen JH et al. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels J Clin Endocrinol Metab 1997 82: 3976–3981
Michaelsen KF, Astrup AV, Mosekilde L et al. The Role of Nutrition in the Prevention of Osteoporosis The Danish Nutrition Council: Copenhagen 1995
Cole TJ, Green PJ . Smoothing reference centile curves: the LMS method and penalized likelihood Stat Med 1992 11: 1305–1319
SAS Institute Inc . SAS/STAT(R) User's Guide, version 6. 4th rev edn SAS Institute Inc: Cary, NC 1989
Prentice A, Parsons TJ, Cole TJ . Uncritical use of bone mineral density in absorbtiometry may lead to size-related artifacts in the identification of bone mineral determinants Am J Clin Nutr 1994 60: 837–842
Gilsanz V, Carlson ME, Roe TF, Ortega JA . Osteoporosis after cranial irradiation for acute lymphoblastic leukemia J Pediatr 1990 117: 238–244
Nussey SS, Hyer SL, Brada M, Leiper AD . Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy (published erratum appears in Acta Paediatr 1995; 84: 620) Acta Paediatr 1994 83: 9–15
Eifel PJ, Donaldson SS, Thomas PR . Response of growing bone to irradiation: a proposed late effects scoring system Int J Radiat Oncol Biol Phys 1995 31: 1301–1307
Cohen A, Van Lint MT, Uderzo C et al. Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood Bone Marrow Transplant 1995 15: 343–348
Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M . Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset J Clin Endocrinol Metab 1992 74: 118–123
de Boer H, Blok GJ, van Lingen A et al. Consequences of childhood-onset growth hormone deficiency for adult bone mass J Bone Miner Res 1994 9: 1319–1326
Vandeweghe M . Can we predict and prevent adult morbidity in males with childhood-onset growth hormone deficiency? Acta Paediatr Suppl 1997 423: 121–123
Parsons TJ, Prentice A, Smith EA et al. Bone mineral mass consolidation in young British adults J Bone Miner Res 1996 11: 264–274
Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency J Clin Endocrinol Metab 1998 83: 379–381
Behre HM, Kliesch S, Leifke E et al. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men J Clin Endocrinol Metab 1997 82: 2386–2390
Hergenroeder AC . Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults J Pediatr 1995 126: 683–689
Schott AM, Cormier C, Hans D et al. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study Osteoporos Int 1998 8: 247–254
Meyer HE, Tverdal A, Falch JA . Risk factors for hip fracture in middle-aged Norwegian women and men Am J Epidemiol 1993 137: 1203–1211
Joakimsen RM, Fønnebø V, Magnus JH et al. The Tromsø Study: body height, body mass index and fractures Osteoporos Int 1998 8: 436–442
Acknowledgements
We thank Tim Cole for helpful comments on LMS modelling of control data. We thank East Danish Research Forum on Health Sciences for statistical advice. Karsten Nysom received financial support from the E Danielsen and Wife Foundation, the Agnes and Poul Friis Foundation, the Jens Christensen and Wife Korna Christensen Foundation, and the Ib Henriksen Foundation. Kirsten Holm received financial support from the Danish Cancer Society (grant No. 92–016). Christian Mølgaard received financial support from FøTEK (Food Technology Research and Development Programme) and the Danish Dairy Research Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nysom, K., Holm, K., Michaelsen, K. et al. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 25, 191–196 (2000). https://doi.org/10.1038/sj.bmt.1702131
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702131
Keywords
This article is cited by
-
Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer
Osteoporosis International (2015)
-
Bone mineral deficits in recipients of hematopoietic cell transplantation: the impact of young age at transplant
Bone Marrow Transplantation (2014)
-
Bone Morbidity in Childhood Leukemia: Epidemiology, Mechanisms, Diagnosis, and Treatment
Current Osteoporosis Reports (2014)